MedPath
NMPA Approval

Antiradon for Injection

国药准字H20066741

August 4, 2021

国药准字H20066741

Drug Information

注射用乙胺硫脲

注射剂

0.25g

化学药品

August 4, 2021

Company Information

Applicant Company

山西省大同经济技术开发区第一医药园区

Manufacturing Company

山西省大同经济技术开发区第一医药园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用乙胺硫脲 - NMPA 批准文号 | MedPath